Istraživanje humanog prion proteina (PrP) i PrP gena
DOI:
https://doi.org/10.5644/Radovi.344Abstract
No abstract available.
References
Bayer Advisory Council on Bioethics. (1998). Creutzfeldt-Jakob disease, blood and blood products: A bioethics framework. Ottawa, Canada: Bayer Advisory Council on Bioethics.
Brown, P., Cervenfikov, L., McShane, I. M., Barber, P., Rubenstein, R., & Drohan, W. N. (1999). Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit CJD in humans. Transfusion, 39, 1169–1178.
Bruce, M. E., Will, R. G., Ironside, J. W., McConnell, L., Drummond, D., Suttie, A., McCardie, L., Chree, A., Hope, J., Birkett, C., Cousens, S., Fraser, H., & Bostock, C. J. (1997). Transmissions to mice indicate that “new variant” CJD is caused by the BSE agent. Nature, 398, 489–501.
Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J., & Hill, A. F. (1996). Molecular analysis of prion strain variation and the aetiology of “new variant” CJD. Nature, 383, 685–690.
Fischer, M. B., Roeckl, C., Parizek, P., Schwarz, H. P., & Aguzzi, A. (2000). Binding of disease-associated prion protein to plasminogen. Nature Medicine, 6, 479–483.
Gibbs, C. J., Jr., Gajdusek, D. C., Asher, D. M., Alpers, M. P., Beck, K., Daniel, P. M., & Matthews, W. P. (1968). Creutzfeldt-Jakob disease (spongiform encephalopathy): Transmission to the chimpanzee. Science, 161, 388–389.
Goldfarb, L. G., Brown, P., McCombie, W. R., Goldgaber, D., Swergold, G. D., Wills, P. R., Cervenakova, L., Baron, H., Gibbs, C. J., Jr., & Gajdusek, D. C. (1991a). Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proceedings of the National Academy of Sciences USA, 88, 10926–10930.
Goldfarb, L. G., Haltia, M., Brown, P., Nieto, A., Kovanen, J., McCombie, W. R., Trapp, S., & Gajdusek, D. C. (1991c). New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred. Lancet, 337, 425.
Goldfarb, L. G., Brown, P., Mitrova, E., Cervenakova, L., Goldin, L., Korczyn, A. D., Chapman, J., Galvez, S., Cartier, L., Rubenstein, R., et al. (1991b). Creutzfeldt-Jakob disease associated with the PRNP codon 200 Lys mutation: An analysis of 45 families. European Journal of Epidemiology, 7, 477–486.
Kretzschmar, H. A., Ironside, J. W., DeArmond, S. J., & Tateishi, J. (1996). Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Archives of Neurology, 53, 913–920.
Laplanche, J. L., Delasnerie-Laupretre, N., Brandel, J. P., Chatelain, J., Beaudry, P., Alperovitch, A., & Launay, J. M. (1994). Molecular genetics of prion diseases in France. Neurology, 44, 2347–2351.
Masters, C. L., Harris, J. O., Gajdusek, D. C., Gibbs, C. J., Jr., Bernoulli, C., & Asher, D. M. (1979). Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering. Annals of Neurology, 5, 177–188.
Mastrianni, J. A., Iannicola, C., Myers, R. M., DeArmond, S., & Prusiner, S. B. (1996). Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease. Neurology, 47, 1305–1312.
Medori, R., Tritschler, H. J., LeBlanc, A., Villare, F., Manetto, V., Chen, H. Y., Xue, R., Leal, S., Montagna, P., Cortelli, B., Tinuper, P., Avoni, P., Moghi, M., Baruzzi, A., Hauw, J. J., Ott, J., Lugaresi, E., & Gambetti, P. (1992). Fatal familial insomnia: A prion disease with a mutation at codon 178 of the prion protein gene. New England Journal of Medicine, 326, 444–449.
Pocchiari, M., Salvatore, M., Cutruzzola, F., Genuardi, M., Allocatelli, C. T., Masullo, C., Macchi, G., Alemà, G., Galgani, S., Xi, Y. G., Petraroli, R., Silvestrini, M. C., & Brunori, M. (1993). A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Annals of Neurology, 34, 802–807.
Prusiner, S. B., Collinge, J., Powell, J., & Anderton, B. (1992). Prion diseases of humans and animals. New York: Ellis Horwood.
Prusiner, S. B. (1991). Molecular biology of prion diseases. Science, 252, 1515–1522.
Sutherland, K., Barrie, C., & Ironside, J. W. (1994). Automatic quantification of amyloid plaque formation in human spongiform encephalopathy. Neurodegeneration, 3, 293–300.
Sutherland, K., Goodbrand, L. A., Bell, J. E., & Ironside, J. W. (1996). Objective quantification of prion protein in spinal cords of cases of CJD. Analytical Cellular Pathology, 10, 25–35.
Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A., & Smith, P. G. (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921–925.
Windl, O., Giese, A., Schulz-Schaeffer, W., Zerr, I., Skworc, K., Arendt, S., Oberdieck, C., Bodemer, M., Poser, S., & Kretzschmar, H. A. (1999). Molecular genetics of human prion diseases in Germany. Human Genetics, 105, 244–252.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Đemo Subašić, Faruk Konjhodžić, Džemal Rezaković, Kemal Šerić, Irma Salimović, Rijad Konjhodžić, Faris Gavrankapetanović
This work is licensed under a Creative Commons Attribution 4.0 International License.
